Author

E. Lechman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

A. Arruda· 1 shared A. Mitchell· 1 shared B. Gratton· 1 shared E. Wagenblast· 1 shared J. C. Wang· 1 shared J. E. Dick· 1 shared J. L. Araujo· 1 shared J. McLeod· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Arruda

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cells

J. L. Araujo, E. Wagenblast, V. Voisin, J. McLeod, O. I. Gan, S. Bansal, L. Jin, A. Mitchell, B. Gratton, S. Cutting, A. Arruda, M. Doedens, J.-M. Capo-Chichi, S. Abelson, M. D. Minden, , J. E. Dick

This study shows FLT3 is essential for ITD-mutated leukemic stem cells but not for normal hematopoietic stem cells, supporting targeted therapies for AML.

bioRxiv · Jun 30, 2024Cancer Biology